Ledger.Open graph →
SEC Form D · filed February 24, 2021

Rgenix, Inc

Offering
$11.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
New York, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

David Darst · New York, NYExecMasoud Tavazoie · New York, NYExec · DirectorJue Pu · New York, NYDirectorPeter Van Vlasselaer · SOUTH SAN FRANCISCO, CADirectorEric Rowinsky · New York, NYExec · DirectorDaniel Lewis · Sagaponack, NYExecBrian Austin · Portland, ORExec · DirectorNancy Chang · New York, NYDirectorAntoine Papiernik · Paris, I0DirectorNilesh Kumar · Menlo Park, CADirectorSaeed Tavazoie · New York, NYExec · DirectorMichael Garvey · Carmel, INExecSteven L. Kiel · Livingston, TXExec · DirectorJue Pu · New York, NYDirectorNancy Chang · Houston, TXDirectorPeter Van Vlasselaer · SOUTH SAN FRANCISCO, CADirectorAntoine Papiernik · New York, NYDirectorNilesh Kumar · Menlo Park, CADirectorSaeed Tavazoie · New York, NYExec · DirectorEric Rowinsky · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗